Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Jane Reusch to Diabetic Angiopathies

This is a "connection" page, showing publications Jane Reusch has written about Diabetic Angiopathies.

 
Connection Strength
 
 
 
1.660
 
  1. Mason McClatchey P, Bauer TA, Regensteiner JG, Schauer IE, Huebschmann AG, Reusch JEB. Dissociation of local and global skeletal muscle oxygen transport metrics in type 2 diabetes. J Diabetes Complications. 2017 Aug; 31(8):1311-1317.
    View in: PubMed
    Score: 0.515
  2. Reusch JE, Wang CC. Cardiovascular disease in diabetes: where does glucose fit in? J Clin Endocrinol Metab. 2011 Aug; 96(8):2367-76.
    View in: PubMed
    Score: 0.340
  3. Reusch JE, Draznin BB. Atherosclerosis in diabetes and insulin resistance. Diabetes Obes Metab. 2007 Jul; 9(4):455-63.
    View in: PubMed
    Score: 0.260
  4. Reusch JE. Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose? J Clin Invest. 2003 Oct; 112(7):986-8.
    View in: PubMed
    Score: 0.200
  5. Scalzo RL, Moreau KL, Ozemek C, Herlache L, McMillin S, Gilligan S, Huebschmann AG, Bauer TA, Dorosz J, Reusch JE, Regensteiner JG. Exenatide improves diastolic function and attenuates arterial stiffness but does not alter exercise capacity in individuals with type 2 diabetes. J Diabetes Complications. 2017 Feb; 31(2):449-455.
    View in: PubMed
    Score: 0.123
  6. Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JE. Diabetes and advanced glycoxidation end products. Diabetes Care. 2006 Jun; 29(6):1420-32.
    View in: PubMed
    Score: 0.060
  7. Bergenstal RM, Nag SS, Reusch JE, Sajjan SG, Alexander CM. Macrovascular risk factors in patients with diabetes: physician treatment strategies and extent of control. Endocr Pract. 2005 May-Jun; 11(3):172-9.
    View in: PubMed
    Score: 0.056
  8. Reusch JE, Gadsby R. Thiazolidinedione therapy: the benefits of aggressive and early use in type 2 diabetes. Diabetes Technol Ther. 2003; 5(4):685-93.
    View in: PubMed
    Score: 0.048
  9. Eckel RH, Wassef M, Chait A, Sobel B, Barrett E, King G, Lopes-Virella M, Reusch J, Ruderman N, Steiner G, Vlassara H. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation. 2002 May 07; 105(18):e138-43.
    View in: PubMed
    Score: 0.045
  10. Haskins K, Bradley B, Powers K, Fadok V, Flores S, Ling X, Pugazhenthi S, Reusch J, Kench J. Oxidative stress in type 1 diabetes. Ann N Y Acad Sci. 2003 Nov; 1005:43-54.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)